2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists
Since the publication of its first Core Cardiovascular Training Statement (COCATS) in 1995,1 the American College of Cardiology (ACC) has defined the knowledge, experiences, skills, and behaviors expected of clinical cardiologists. Subsequent revisions have moved toward competency-based training based on the 6-domain competency structure promulgated by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties and endorsed by the American Board of Internal Medicine (ABIM).
Publication date: Available online 9 October 2020Source: Revista Española de Cardiología (English Edition)Author(s): Francisco González-Vilchez, Luis Almenar-Bonet, María G. Crespo-Leiro, Manuel Gómez-Bueno, José González-Costello, Félix Pérez-Villa, Juan Delgado-Jiménez, José María Arizón del Prado, José Manuel Sobrino-Márquez, Iago Sousa Casasnovas, on behalf of the Spanish Heart Transplant Teams, Collaborators in the Spanish Heart Transplant Registry, 1984-2019, Javier Segovia-Cubero, Francisco Hernández-P&eac...
Conclusions: Somatostatin concentrations were associated with CVP and CI in patients with HF. The pathophysiological mechanism may be related to congestion and/or hypoperfusion of the intestine. Somatostatin was an independent predictor of mortality in advanced HF.Cardiology
Conclusion In our experience, more than one-third of the patients were able to tolerate the higher dose of sacubitril/valsartan, and these patients were younger, had higher Hb, and better BP and renal function. MECKI score stratification was useful to discriminate patients who continued treatment from those who did not. Future prospective studies should test if these clinical variables can guide the up-titration of sacubitril/valsartan.
Conclusions: IAB is associated with new-onset AF and death in CRT recipients and may be helpful in the risk stratification in the context of heart failure management. Abnormal PTFV1 did not demonstrate any prognostic value.Cardiology
Conclusion A 5-day universal decolonization protocol before LVAD implantation was effective in reducing total infections as well as MRSA-specific infections.
ConclusionsConcomitant AoV surgery in patients undergoing LVAD implantation is an independent predictor of mortality. Additional research is needed to determine the best AoV surgical strategy at the time of LVAD surgery.
CONCLUSION: A 5-day universal decolonization protocol before LVAD implantation was effective in reducing total infections as well as MRSA-specific infections. PMID: 33009271 [PubMed - as supplied by publisher]
Conclusions: The costs of specialised care decreased with the length of hospital stay reduction. Cardiovascular risk factors were crucial in in-hospital mortality. This study provides population-based data to assist decision-makers at the national level and to contribute to worldwide evaluations and disease surveillance. PMID: 33000981 [PubMed - as supplied by publisher]
Conclusion: CPSS may be a more likely cause of unexplained PAH in pediatric patients than previously thought. Shunt closure or liver transplantation may prevent the progression of PAH, or even improve it for the majority of CPSS patients.What is Known:•Congenital portosystemic shunts (CPSS) are increasingly recognized as a cause of pulmonary arterial hypertension (PAH) in children, but the prevalence of CPSS in pediatric PAH patients is largely unknown, and the therapeutic outcomes of these conditions are not well described.What is New:•This is the largest cohort of CPSS-associated PAH ever published. CPSS may be...
CONCLUSION: Wide variation exists in the care delivered and/or resources available for patients with CS. Our survey suggests opportunities for standardization of care. PMID: 32999090 [PubMed - in process]